Elo Mutual Pension Insurance Co Has $1.16 Million Stake in Revvity, Inc. (NYSE:RVTY)

Elo Mutual Pension Insurance Co trimmed its stake in Revvity, Inc. (NYSE:RVTY) by 1.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,061 shares of the company’s stock after selling 127 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Revvity were worth $1,160,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Rothschild Investment LLC acquired a new stake in Revvity in the second quarter valued at $25,000. Logan Capital Management Inc. acquired a new stake in Revvity in the fourth quarter valued at $37,000. Family Firm Inc. acquired a new stake in Revvity in the second quarter valued at $43,000. Fairfield Financial Advisors LTD acquired a new stake in Revvity in the second quarter valued at $43,000. Finally, Parallel Advisors LLC acquired a new stake in Revvity in the fourth quarter valued at $47,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Price Performance

RVTY stock opened at $122.89 on Friday. Revvity, Inc. has a 1 year low of $79.50 and a 1 year high of $128.15. The stock has a market capitalization of $15.16 billion, a PE ratio of 101.56, a price-to-earnings-growth ratio of 2.87 and a beta of 1.05. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.98. The company’s 50-day moving average is $119.06 and its 200-day moving average is $110.57.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Monday, July 29th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.10. Revvity had a net margin of 6.26% and a return on equity of 7.34%. The business had revenue of $691.70 million for the quarter, compared to analysts’ expectations of $690.33 million. During the same quarter last year, the firm earned $1.21 EPS. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. Equities research analysts expect that Revvity, Inc. will post 4.75 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Friday, October 18th will be given a $0.07 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.28 annualized dividend and a yield of 0.23%. Revvity’s payout ratio is 23.14%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. Wells Fargo & Company assumed coverage on Revvity in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $130.00 price objective for the company. Leerink Partnrs raised shares of Revvity to a “strong-buy” rating in a research report on Monday, July 8th. Jefferies Financial Group upped their price target on shares of Revvity from $115.00 to $125.00 and gave the company a “hold” rating in a research report on Monday, July 29th. Barclays upped their price target on shares of Revvity from $115.00 to $125.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 30th. Finally, TD Cowen upped their price target on shares of Revvity from $130.00 to $141.00 and gave the company a “buy” rating in a research report on Tuesday, July 30th. Eight equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $126.00.

Insider Activity at Revvity

In other Revvity news, insider Joel S. Goldberg sold 3,500 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $117.86, for a total value of $412,510.00. Following the completion of the sale, the insider now owns 33,400 shares in the company, valued at approximately $3,936,524. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.60% of the stock is owned by insiders.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.